As per this latest industry analysis by Fact.MR, a market research and competitive intelligence provider, the global vaginal slings market is currently valued at US$ 2.07 billion and is predicted to expand at a CAGR of 4.5% from 2022 to 2032.
Vaginal slings are used to treat urinary incontinence, an undiscovered disorder in which an involuntary urine leaking happens as a result of losing control of the bladder. Loud laughter, sneezing, coughing, lifting heavy objects, and exercise can all cause urine leakage. Vaginal slings support and uphold the bladder and urethra like a hammock to stop this leakage or unwelcome flow of pee.
Download Sample Copy of This Report –
Vaginal slings are divided into several categories according to type, including pubovaginal slings, tension-free vaginal tape slings, conventional vaginal slings, advanced vaginal slings, tiny slings/single incision slings, and transobturator slings. Due to benefits such a minimal risk of bladder, intestine, and major blood artery injuries, and efficient results, the demand for transobturator slings is anticipated to increase at a healthy development rate.
Due to the increased prevalence of urine incontinence, it is predicted that the global vaginal slings market would expand throughout the forecast period. Numerous studies show that females have urine incontinence more frequently than males. The demand for minimally invasive vaginal sling surgeries is expected to be significantly higher than that for invasive procedures used to insert slings during the course of the projection period.
Due to the high incidence of urine incontinence condition, the presence of significant companies, and the presence of modern healthcare facilities, North America and Europe are likely to lead the worldwide vaginal slings market expansion. In the Asia Pacific area, demand for vaginal sling products is anticipated to grow at a strong CAGR over the next 10 years.
Key Takeaways from Market Study
- Global sales of vaginal slings are expected to reach US$ 3.21 billion by 2032.
- China’s vaginal slings market is expected to expand at a CAGR of 8% from 2022 to 2032.
- Demand for transobturator slings is predicted to rise at a CAGR of 5% from 2022 to 2032.
- Hospitals are expected to account for the highest usage of vaginal slings during the forecast period.
Get Customization on this Report for Specific Research Solutions –
Vaginal sling sales growth is expected to be constrained by the high risk of failure or urinary tract infections (UTIs) associated with treatment methods for vaginal slings and the lack of awareness of such therapy in developing nations. A high demand for vaginal sling items from hospitals is anticipated during the anticipated time period as a result of the availability of cutting-edge medical technologies and qualified healthcare personnel.
Key manufacturers of vaginal slings are focused on launching advanced vaginal sling products for the treatment of urinary incontinence.
Rising cases related to urological disorders and the growing senior population with target diseases are expected to generate profitable opportunities for manufacturers of vaginal slings.
- Triple W introduced a digitally connected urinary incontinence device in January 2019 that tracks bladder capacity and sends notifications when it’s time to urinate.
- In January 2019, Leonhardt’s Launchpads unveiled the “BladderCell”, a cutting-edge technology that uses bioelectric mode to treat bladder problems.
- Boston Scientific Corporation, one of the top market players, has a wide range of product folio with advanced vaginal sling solutions, used in the treatment of urinary disorders.
- For people with stress urine incontinence, Boston Scientific Corporation introduced the AdVance XP Male Sling System in February 2019.
- For instance, Desara TVez, a pelvic sling system developed by Caldera Medical in December 2021 to treat women with stress urinary incontinence and other pelvic health issues, is the latest addition to the Desara family of pelvic sling systems.
Key Companies Profiled
- Becton, Dickinson Company
- Betatech Medical
- Boston Scientific Corporation
- Caldera Medical, Inc.
- Coloplast A/S
- Cook Medical, Inc.
- Ethicon US LLC
- ProSurg, Inc.
Get Full Access of Complete Report –
Key Segments of Vaginal Slings Industry Research
- By Type:
- Transobturator Slings
- Mini Slings/Single Incision Slings
- Conventional Vaginal Slings
- Advanced Vaginal Slings
- Tension-free Vaginal Tape Slings
- Pubovaginal Slings
- By Material Type:
- Tissue Slings
- Synthetic Slings
- By Type of Urinary Incontinence:
- Urge Urinary Incontinence
- Stress Urinary Incontinence
- Mixed Urinary Incontinence
- By End User:
- Ambulatory Surgical Centers
- By Region:
- North America
- Latin America
- East Asia
- South Asia & Oceania
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global vaginal slings market, presenting historical demand data (2017-2021) and forecast statistics for the period of 2022-2032.
The study divulges essential insights on the market on the basis of type (transobturator slings, mini slings/single incision slings, conventional vaginal slings, advanced vaginal slings, tension-free vaginal tape slings, pubovaginal slings), material type (tissue slings, synthetic slings), type of urinary incontinence (urge urinary incontinence, stress urinary incontinence, mixed urinary incontinence), and end user (hospitals, clinics, ambulatory surgical centers), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Check out more related studies published by Fact.MR Research:
Urinary Tract Infection Treatment Market – The global urinary tract infection treatment market was valued at US$ 10.5 Bn in 2021, and is expected to increase at a CAGR of 2.1% to reach US$ 12.9 Bn by 2031. As per industry analysis by Fact.MR, a market research and competitive intelligence provider, sales of urinary tract infection treatment solutions and devices increased at a CAGR of 1.5% from 2016 to 2020.
Genitourinary Cancers Treatment Market – Increase in the incidence of genitourinary cancers is a prime driver of the genitourinary cancers treatment market. According to the National Cancer Institute, prostate cancer accounted for 164,690 new cases in 2018, thus accounting for 9.5% of all new cancer cases.
Minimally Invasive Surgery Market – The global minimally invasive surgery market is likely to be valued at US$ 6.31 Billion in FY 2022, up from US$ 6 Billion in 2021. During the past year, the industry registered a Y-o-Y increase worth 5.2%. From 2022 to 2032, the market is poised to flourish at a CAGR of 5.2% to reach a value of US$ 10.5 Billion.
Stress Urinary Incontinence Market – The introduction of innovative urinary catheters coupled with rising preference for minimal invasive surgical treatment of stress urinary incontinence to achieve early cure has registered to be prominent driving factor responsible for revenue generation in global stress urinary incontinence market. The growing geriatric population more prone to develop stress urinary incontinence along with availability of wide range of treatment options for stress urinary incontinence such as antidepressants, urethral slings, and urinary catheters is expected to be another factor propelling the revenue growth of global stress urinary incontinence market.
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. We are committed to deliver insights that help businesses gain deeper understanding of their target markets. We understand that making sense of the vast labyrinth of data can be overwhelming for businesses. That’s why focus on offering insights that can actually make a difference to bottom-lines.
Specialties: Competition Tracking, Customized Research, Syndicated Research, Investment Research, Social Media Research, Business Intelligence, Industry Analysis, Thought Leadership.